AFNT-111: A novel TCR-engineered T cell therapy targeting the oncogenic driver KRAS G12V

被引:0
|
作者
Hoffmann, Michele [1 ]
He, Xingyue [1 ]
Black, Cheryl [2 ]
Francis, Joshua [1 ]
Parsons, James [2 ]
Roy, Christian [1 ]
Liang, Jinsheng [1 ]
Qu, Hongjing [1 ]
Campbell, Martin [2 ]
Sewastianik, Tomasz [1 ]
Webb, Jessica [3 ]
Chapuis, Aude [3 ]
Schmitt, Thomas [3 ]
Greenberg, Philip [3 ]
Hallet, Damien [1 ]
Vallaster, Markus [1 ]
Pierog, Piotr [1 ]
Shapiro, Gary [1 ]
Lam, Hubert [1 ]
Vincent, Loic [1 ]
机构
[1] Affini T Therapeut, Watertown, MA USA
[2] Affini T Therapeut, Seattle, WA USA
[3] Fred Hutchinson Canc Res Ctr, Seattle, WA USA
关键词
D O I
10.1158/1557-3125.RAS23-A009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A009
引用
收藏
页数:2
相关论文
共 23 条
  • [1] AFNT-111, A SAFE AND EFFECTIVE TCR-ENGINEERED T CELL THERAPY TARGETING THE ONCOGENIC DRIVER KRAS G12V MUTATION
    Lam, Hubert
    He, Xingyue
    Black, Cheryl
    Hoffmann, Michele
    Francis, Joshua
    Parsons, James
    Roy, Christian
    Liang, Jinsheng
    Qu, Hongjing
    Campbell, Martin
    Sewastianik, Tomasz
    Webb, Jessica
    Chapuis, Aude
    Schmitt, Thomas
    Greenberg, Philip
    Hallet, Damien
    Vallaster, Markus
    Pierog, Piotr
    Shapiro, Gary
    Vincent, Loic
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A259 - A259
  • [2] KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors
    Dan Lu
    Yuan Chen
    Min Jiang
    Jie Wang
    Yiting Li
    Keke Ma
    Wenqiao Sun
    Xing Zheng
    Jianxun Qi
    Wenjing Jin
    Yu Chen
    Yan Chai
    Catherine W. H. Zhang
    Hao Liang
    Shuguang Tan
    George F. Gao
    [J]. Nature Communications, 14
  • [3] KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors
    Lu, Dan
    Chen, Yuan
    Jiang, Min
    Wang, Jie
    Li, Yiting
    Ma, Keke
    Sun, Wenqiao
    Zheng, Xing
    Qi, Jianxun
    Jin, Wenjing
    Chen, Yu
    Chai, Yan
    Zhang, Catherine W. H.
    Liang, Hao
    Tan, Shuguang
    Gao, George F.
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [4] Generating optimal-affinity T cell receptors targeting the shared neoantigen KRAS G12V using the humanized TCR transgenic mouse platform HuTCR
    Leliavski, Alexei
    Knackstedt, Lorenz
    Oduro, Jennifer
    Selck, Claudia
    Dhamodaran, Arunraj
    Blankenstein, Thomas
    Kieback, Elisa
    Poncette, Lucia
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [5] AFNT-211: An FAS-41BB-enhanced TCR-T cell therapy with stem-like properties targeting KRAS G12V-expressing solid tumors
    Hoffmann, Michele
    Brown, Lauren
    Campbell, Martin
    Pechhold, Klaus
    He, Xingyue
    Lee, Joseph
    Qu, Hongjing
    Liang, Jinsheng
    Chapuis, Aude
    Greenberg, Philip D.
    Nagorsen, Dirk
    Vallaster, Markus P.
    Canestraro, Martina
    Lam, Hubert
    Shapiro, Gary
    Hallet, Damien
    Nguyen, Kim
    Vincent, Loic
    Schmitt, Thomas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Potent antitumor activity of a bispecific T-cell engager antibody targeting the intracellular antigen KRAS G12V
    Lu, Changchang
    Zou, Lu
    Wang, Qiaoli
    Sun, Mengna
    Shi, Tianyu
    Xu, Shuang
    Meng, Fanyan
    Du, Juan
    [J]. BIOMOLECULES AND BIOMEDICINE, 2024, 24 (05): : 1424 - 1434
  • [7] Preclinical Development of Safe and Effective T Cell Receptors Specific for Mutant KRAS G12V and G12D Peptides
    Martinov, Tijana
    Perret, Rachel
    Mureli, Shwetha
    McCurdy, Clara
    Vazquez, Angie
    Lee, Jihoon
    Webb, Jessica
    Black, Cheryl
    Parsons, James
    Francis, Joshua
    Lam, Hubert
    Shapiro, Gary
    Vincent, Loic
    Chapuis, Aude
    Schmitt, Thomas
    Greenberg, Philip
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 55 - 55
  • [8] Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma
    Wachsmann, Tassilo L. A.
    Meeuwsen, Miranda H.
    Remst, Dennis F. G.
    Buchner, Karen
    Wouters, Anne K.
    Hagedoorn, Renate S.
    Falkenburg, J. H. Frederik
    Heemskerk, Mirjam H. M.
    [J]. BLOOD ADVANCES, 2023, 7 (20) : 6178 - 6183
  • [9] TCR-mimic antibody-drug conjugates targeting intracellular tumor-specific mutant antigen KRAS G12V mutation
    Ying Shen
    Xiaoyue Wei
    Shijie Jin
    Yue Wu
    Wenbin Zhao
    Yingchun Xu
    Liqiang Pan
    Zhan Zhou
    Shuqing Chen
    [J]. Asian Journal of Pharmaceutical Sciences, 2020, 15 (06) : 777 - 785
  • [10] TCR-mimic antibody-drug conjugates targeting intracellular tumor-specific mutant antigen KRAS G12V mutation
    Shen, Ying
    Wei, Xiaoyue
    Jin, Shijie
    Wu, Yue
    Zhao, Wenbin
    Xu, Yingchun
    Pan, Liqiang
    Zhou, Zhan
    Chen, Shuqing
    [J]. ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 15 (06) : 777 - 785